ImmunityBio Inc. Common Stock vs Powell Industries — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Powell Industries trades at $194 (market cap $6.89B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Powell Industries pays a 0.19% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Powell Industries for 4 Days on average.
| IBRX | POWL | |
|---|---|---|
Market Cap | $10.51B | $6.89B |
Volume | 10,445,785 | 728,725 |
Sector | Health | Industrials |
52-Week High | $11.55 | $322.05 |
52-Week Low | $1.98 | $94.02 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $10.97B | $6.26B |
Dividend Yield | — | 0.19% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →